| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 08/15/2021 |
3. Issuer Name and Ticker or Trading Symbol
TEVA PHARMACEUTICAL INDUSTRIES LTD [ TEVA ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Ordinary Shares(1) | 4,828 | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Restricted Share Units | (2) | (2) | Ordinary Shares(1) | 22,842 | (3) | D | |
| Restricted Share Units | (4) | (4) | Ordinary Shares(1) | 14,485 | (3) | D | |
| Stock Options (Right to Buy) | (5) | 11/14/2021 | Ordinary Shares(1) | 3,450 | $19.16 | I | By Spouse |
| Stock Options (Right to Buy) | (6) | 11/14/2021 | Ordinary Shares(1) | 2,255 | $34.7 | I | By Spouse |
| Explanation of Responses: |
| 1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
| 2. Restricted share units were granted on March 5, 2021, with 5,710 vesting on each of March 5, 2022, March 5, 2023 and March 5, 2024 and 5,712 vesting on March 5, 2025. |
| 3. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 4. Restricted share units were granted on February 28, 2020, with 4,828 vesting on each of February 28, 2022 and February 28, 2023 and 4,829 vesting on February 28, 2024. |
| 5. Stock Options were granted on March 3, 2018, with 1,150 vested on each of March 2, 2019, March 2, 2020 and March 2, 2021. |
| 6. Stock Options were granted on March 3, 2017, with 563 vested on each of March 3, 2018, March 3, 2019 and March 3, 2020 and 566 vested on March 3, 2021. |
| Remarks: |
| EVP, Chief Human Resources Officer and Head of Global Communications, Brand and ESG |
| /s/ Dov Bergwerk as attorney-in-fact for Galia Inbar | 08/19/2021 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||